| scholarly article | Q13442814 |
| P50 | author | Masakazu Kamata | Q59160346 |
| Hans-Peter Kiem | Q88408730 | ||
| Anjie Zhen | Q89747348 | ||
| Christopher W Peterson | Q89747350 | ||
| Sowmya Somashekar Reddy | Q89747353 | ||
| Brianna B Lam | Q89747356 | ||
| Jennifer Kim | Q89747358 | ||
| Valerie K Rezek | Q89747361 | ||
| P2093 | author name string | Jerome A Zack | |
| Scott G Kitchen | |||
| Irvin S Y Chen | |||
| Jonathan W Rick | |||
| Heather A Martin | |||
| Cindy S Youn | |||
| Mayra A Carrillo | |||
| Nelson Y Chang | |||
| Nick C Neel | |||
| P2860 | cites work | In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells | Q21559398 |
| Stem-cell-based gene therapy for HIV infection | Q24607667 | ||
| Chimeric antigen receptor T-cell therapy for solid tumors | Q26750908 | ||
| Advantages and applications of CAR-expressing natural killer cells | Q28080875 | ||
| Utilizing chimeric antigen receptors to direct natural killer cell activity | Q28082868 | ||
| Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
| Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection | Q33854184 | ||
| Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement. | Q33933120 | ||
| Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates. | Q33968014 | ||
| A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. | Q34205743 | ||
| Toxicity management for patients receiving novel T-cell engaging therapies. | Q34343346 | ||
| B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers | Q35058635 | ||
| Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells | Q35202343 | ||
| Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity | Q35745453 | ||
| Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys | Q35848120 | ||
| Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation | Q36067042 | ||
| Novel TRIM5 isoforms expressed by Macaca nemestrina | Q36315442 | ||
| Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs | Q36481483 | ||
| Persistent Simian Immunodeficiency Virus Infection Drives Differentiation, Aberrant Accumulation, and Latent Infection of Germinal Center Follicular T Helper Cells | Q36481555 | ||
| Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy | Q36541079 | ||
| Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells | Q36598618 | ||
| Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS | Q36613666 | ||
| Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV | Q36654098 | ||
| Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors | Q36713507 | ||
| HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells | Q36757040 | ||
| Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation | Q36796554 | ||
| Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases | Q36915157 | ||
| Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates | Q36920437 | ||
| Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model. | Q37006885 | ||
| Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection | Q37169285 | ||
| Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus | Q37287933 | ||
| HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads. | Q37300347 | ||
| Design and development of therapies using chimeric antigen receptor-expressing T cells | Q37418289 | ||
| Hematopoietic stem cells for cancer immunotherapy | Q37512048 | ||
| Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation | Q37661792 | ||
| Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector | Q38926281 | ||
| Cell-Intrinsic Barriers of T Cell-Based Immunotherapy | Q39003162 | ||
| Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects | Q41750120 | ||
| A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy | Q44165805 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P304 | page(s) | e1006753 | |
| P577 | publication date | 2017-12-28 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS | |
| P478 | volume | 13 |
| Q90639885 | Advances in Developing CAR T-Cell Therapy for HIV Cure |
| Q66679660 | Autologous, Gene-Modified Hematopoietic Stem and Progenitor Cells Repopulate the Central Nervous System with Distinct Clonal Variants |
| Q91868621 | CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases |
| Q90475786 | CAR T cells for infection, autoimmunity and allotransplantation |
| Q64083383 | Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies |
| Q91786100 | Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model |
| Q59359586 | Chimeric antigen receptor T-cell approaches to HIV cure |
| Q55422965 | Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. |
| Q99637221 | Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo |
| Q64109055 | Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection |
| Q67201058 | Gene editing for immune cell therapies |
| Q58604627 | Genetic Strategies for HIV Treatment and Prevention |
| Q95847922 | HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo |
| Q92482546 | Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model |
| Q59359574 | Nanotechnology approaches to eradicating HIV reservoirs |
| Q96952560 | Next-generation stem cells - ushering in a new era of cell-based therapies |
| Q91642187 | Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review |
| Q60938672 | Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases |
| Q63740735 | RNA Viruses as Tools in Gene Therapy and Vaccine Development |
| Q92912382 | Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant |
| Q60046873 | Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction |
| Q92097620 | Why and where an HIV cure is needed and how it might be achieved |
Search more.